Solid Tumors 2025: Technologies, Diagnostics & Therapeutics

Solid Tumors 2025: Technologies, Diagnostics & Therapeutics is organized by Select Biosciences and will be held from Nov 20 - 21, 2025 at voco Laguna Hills, Laguna Hills, California, United States of America.

Description:
We are honored that Roger Royse, Partner at Haynes & Boone, LLP will be serving as Conference Chairperson.

This conference explores innovations in technology development, the development of early-screening methodologies, liquid biopsies, various diagnostic and current therapeutic modalities addressing several classes of solid tumors.

Given that solid tumors represent a challenging target in oncology, the goal of this conference is to bring together researchers, clinicians as well as the drug development community to engage and discuss the latest trends arising from research and their progression into clinical studies and application.

The conference comprises of scientific and clinical presentations, presentations from companies on the screening, diagnostic and therapeutics spaces as well as round-table discussions on latest trends from the scientific and clinical communities.

Topics Addressed at this Conference:

• Progress in Research Trends Targeting Various Classes of Solid Tumors
• Therapeutic Modalities Targeting Solid Tumors
• Childhood Cancers
• Pancreatic Cancer
• Breast, Lung and Colon Cancer
• Early Screening Tests and Tools
• Liquid Biopsy
• Presentations from Academic/Basic Researchers
• Presentations from Companies and Drug Discovery/Development Companies, Pharma-Biotech Companies.